Cargando…

Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis

Sepsis results in lethal organ malfunction due to dysregulated host response to infection, which is a condition with increasing prevalence worldwide. Transglutaminase 2 (TG2) is a crosslinking enzyme that forms a covalent bond between lysine and glutamine. TG2 plays important roles in diverse cellul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Ting, Qin, Xian-Yang, Furutani, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918628/ https://www.ncbi.nlm.nih.gov/pubmed/33672962 http://dx.doi.org/10.3390/ijms22041897

Ejemplares similares

Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
por: Qin, Xian-Yang, et al.
Publicado: (2023)

Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death
por: Tatsukawa, H, et al.
Publicado: (2016)

Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase
por: Liu, Chen, et al.
Publicado: (2017)

A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor
por: Sohn, Joonhong, et al.
Publicado: (2010)

Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies
por: Zhang, Jie, et al.
Publicado: (2021)

Prevention of arachidonic acid-induced liver injury by controlling oxidative stress-mediated transglutaminase activation with garlic extracts
por: Qin, Xian-Yang, et al.
Publicado: (2020)

The Pathogenesis of Sepsis and Potential Therapeutic Targets
por: Huang, Min, et al.
Publicado: (2019)

Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011)

Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers
por: Cho, Sung-Yup, et al.
Publicado: (2020)

Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target
por: Malkomes, Patrizia, et al.
Publicado: (2023)

Transglutaminase 2 in human diseases
por: Szondy, Zsuzsa, et al.
Publicado: (2017)

Inhibition of Ganglioside Synthesis Suppressed Liver Cancer Cell Proliferation through Targeting Kinetochore Metaphase Signaling
por: Su, Ting, et al.
Publicado: (2021)

Biological Functionalities of Transglutaminase 2 and the Possibility of Its Compensation by Other Members of the Transglutaminase Family
por: Odii, Benedict Onyekachi, et al.
Publicado: (2014)

A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
por: Kim, Soo-Youl, et al.
Publicado: (2020)

Transglutaminase is a Critical Link Between Inflammation and Hypertension
por: Luo, Renna, et al.
Publicado: (2016)

Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer
por: Agnihotri, Navneet, et al.
Publicado: (2013)

Biotechnological Applications of Transglutaminases
por: Rachel, Natalie M., et al.
Publicado: (2013)

Transglutaminases in Monocytes and Macrophages
por: Sun, Huifang, et al.
Publicado: (2018)

Transglutaminase in Foods and Biotechnology
por: Vasić, Katja, et al.
Publicado: (2023)

Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction
por: Furini, Giulia, et al.
Publicado: (2019)

Tissue transglutaminase: a new target to reverse cancer drug resistance
por: Budillon, Alfredo, et al.
Publicado: (2011)

The pathogenesis and potential therapeutic targets in sepsis
por: Zhang, Wendan, et al.
Publicado: (2023)

The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment
por: Tempest, Robert, et al.
Publicado: (2021)

Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis
por: Tatsukawa, Hideki, et al.
Publicado: (2021)

Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
por: Bopp, Christian, et al.
Publicado: (2008)

Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors
por: Fell, Shaun, et al.
Publicado: (2021)

Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2)
por: Valdivia, Andres, et al.
Publicado: (2023)

Regulation of Pollen Tube Growth by Transglutaminase
por: Cai, Giampiero, et al.
Publicado: (2013)

The Outside-In Journey of Tissue Transglutaminase in Cancer
por: Sima, Livia Elena, et al.
Publicado: (2022)

Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma
por: Kang, Joon Hee, et al.
Publicado: (2020)

Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016)

Biocatalysis by Transglutaminases: A Review of Biotechnological Applications
por: Savoca, Maria Pia, et al.
Publicado: (2018)

Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma
por: Nezir, Ayca Ece, et al.
Publicado: (2019)

HSP-Target of Therapeutic Agents in Sepsis Treatment
por: Vulczak, Anderson, et al.
Publicado: (2019)

Gases in Sepsis: Novel Mediators and Therapeutic Targets
por: Zhu, Zhixing, et al.
Publicado: (2022)

Arachidonic acid suppresses hepatic cell growth through ROS‐mediated activation of transglutaminase
por: Qin, Xian‐Yang, et al.
Publicado: (2018)

Transglutaminase 2 mediates UV-induced skin inflammation by enhancing inflammatory cytokine production
por: Lee, Seok-Jin, et al.
Publicado: (2017)

The glycocalyx: a novel diagnostic and therapeutic target in sepsis
por: Uchimido, Ryo, et al.
Publicado: (2019)

Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention
por: Hortová-Kohoutková, Marcela, et al.
Publicado: (2020)

Glucose Homeostasis in Mice Is Transglutaminase 2 Independent
por: Iismaa, Siiri E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qkq5muctdrlff3slfrquadshkl